Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.

Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
复制标题

DOI:
10.1016/j.nbd.2022.105808
复制
发表时间:
2022-09
影响因子:
6.1
通讯作者:
Koliatsos, Vassilis E.
Koliatsos, Vassilis E.
中科院分区:
医学1区
文献类型:
--
作者:
Alexandris, Athanasios S.;Ryu, Jiwon;Rajbhandari, Labchan;Harlan, Robert;McKenney, James;Wang, Yiqing;Aja, Susan;Graham, David;Venkatesan, Arun;Koliatsos, Vassilis E.

文献摘要

参考文献

被引文献

相似文献

沃勒变性是一种保守的轴突自毁程序,与几种神经系统疾病有关。WD是由NAD+合成酶NMNA2的降解、底物NMN的积聚和NAD+降解Sarm1的激活而驱动的,最终导致轴突碎裂。这些事件的调节和对治疗干预的适应性仍不清楚。在此,我们探索了调节NMN和NAD+代谢的药物策略,即在体外轴突切断模型中抑制NMN合成酶NAMPT,激活烟酸核苷(NAR)挽救途径和抑制NMNat2降解DLK MAPK途径。结果表明,NAMPT和DLK抑制引起WD显著延迟,但具有时间依赖性。这些时间依赖效应与NMNA2的降解以及NMN和NAD+水平的变化有关。补充NAMPT抑制与NAR具有增强的效果,不依赖于干预的时间,并导致强大的保护长达4天。额外的DLK抑制作用甚至将这一时间延长到6天。代谢产物分析表明,NAMPT和MAPK抑制通过降低NMN水平、改善NAD+损失和抑制Sarm1活性发挥复杂的作用。最后,轴突NAD+/NMN比率是cADPR水平的高度预测,扩大了先前关于Sarm1变构调节的无细胞证据。我们的发现建立了轴突保护窗口,在损伤后持续几个小时。此外,我们显示,通过联合MAPK和NAMPT抑制的混合处理,通过对NAD+代谢的复杂影响和对Sarm1的抑制,可以延长保护时间。
Wallerian degeneration (WD) is a conserved axonal self-destruction program implicated in several neurological diseases. WD is driven by the degradation of the NAD+ synthesizing enzyme NMNAT2, the buildup of its substrate NMN, and the activation of the NAD+ degrading SARM1, eventually leading to axonal fragmentation. The regulation and amenability of these events to therapeutic interventions remain unclear. Here we explored pharmacological strategies that modulate NMN and NAD+ metabolism, namely the inhibition of the NMN-synthesizing enzyme NAMPT, activation of the nicotinic acid riboside (NaR) salvage pathway and inhibition of the NMNAT2-degrading DLK MAPK pathway in an axotomy model in vitro. Results show that NAMPT and DLK inhibition cause a significant but time-dependent delay of WD. These time-dependent effects are related to NMNAT2 degradation and changes in NMN and NAD+ levels. Supplementation of NAMPT inhibition with NaR has an enhanced effect that does not depend on timing of intervention and leads to robust protection up to 4 days. Additional DLK inhibition extends this even further to 6 days. Metabolite analyses reveal complex effects indicating that NAMPT and MAPK inhibition act by reducing NMN levels, ameliorating NAD+ loss and suppressing SARM1 activity. Finally, the axonal NAD+/NMN ratio is highly predictive of cADPR levels, extending previous cell-free evidence on the allosteric regulation of SARM1. Our findings establish a window of axon protection extending several hours following injury. Moreover, we show prolonged protection by mixed treatments combining MAPK and NAMPT inhibition that proceed via complex effects on NAD+ metabolism and inhibition of SARM1.
DOI: 10.1038/s41583-020-0269-3
发表时间: 2020-04
期刊: Nature reviews. Neuroscience
影响因子: --
作者:
Coleman MP;Höke A
通讯作者: Höke A
DOI: 10.1016/j.nbd.2012.02.003
发表时间: 2012-05
影响因子: 6.1
作者:
Fernandes, Kimberly A.;Harder, Jeffrey M.;Fornarola, Laura B.;Freeman, Robert S.;Clark, Abbot F.;Pang, Iok-Hou;John, Simon W. M.;Libby, Richard T.
通讯作者: Libby, Richard T.
DOI: 10.1038/cdd.2014.164
发表时间: 2015-05
影响因子: 12.4
作者:
通讯作者: --
DOI: 10.1016/j.celrep.2020.107999
发表时间: 2020-08-04
期刊: CELL REPORTS
影响因子: 8.8
作者:
Bratkowski, Matthew;Xie, Tian;Sambashivan, Shilpa
通讯作者: Sambashivan, Shilpa
DOI: 10.1016/j.neuron.2017.02.022
发表时间: 2017-03-22
期刊: Neuron
影响因子: 16.2
作者:
Essuman K;Summers DW;Sasaki Y;Mao X;DiAntonio A;Milbrandt J
通讯作者: Milbrandt J